The Evolution of Axillary Staging in Breast Cancer

Roshni Rao

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Breast cancer treatment has a long, fascinating history. Multimodality therapy utilizes surgery, systemic therapy and radiation. The role of surgical axillary staging in breast cancer continues to evolve. Secondary to randomized, controlled trials, sentinel lymph node biopsy is the standard for surgical staging in patients with a clinically negative axilla. Traditionally, when sentinel nodes revealed metastases, a complete axillary lymph node dissection was performed. Recently however, the value of complete axillary dissection is being challenged.

Original languageEnglish (US)
Pages (from-to)385-388
Number of pages4
JournalMissouri Medicine
Volume112
Issue number5
StatePublished - Sep 1 2015

Fingerprint

Breast Neoplasms
Sentinel Lymph Node Biopsy
Axilla
Lymph Node Excision
Dissection
Radiotherapy
Randomized Controlled Trials
History
Neoplasm Metastasis
Therapeutics
cyhalothrin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Evolution of Axillary Staging in Breast Cancer. / Rao, Roshni.

In: Missouri Medicine, Vol. 112, No. 5, 01.09.2015, p. 385-388.

Research output: Contribution to journalArticle

Rao, R 2015, 'The Evolution of Axillary Staging in Breast Cancer', Missouri Medicine, vol. 112, no. 5, pp. 385-388.
Rao, Roshni. / The Evolution of Axillary Staging in Breast Cancer. In: Missouri Medicine. 2015 ; Vol. 112, No. 5. pp. 385-388.
@article{ba078d785ae647c790886742740bd765,
title = "The Evolution of Axillary Staging in Breast Cancer",
abstract = "Breast cancer treatment has a long, fascinating history. Multimodality therapy utilizes surgery, systemic therapy and radiation. The role of surgical axillary staging in breast cancer continues to evolve. Secondary to randomized, controlled trials, sentinel lymph node biopsy is the standard for surgical staging in patients with a clinically negative axilla. Traditionally, when sentinel nodes revealed metastases, a complete axillary lymph node dissection was performed. Recently however, the value of complete axillary dissection is being challenged.",
author = "Roshni Rao",
year = "2015",
month = "9",
day = "1",
language = "English (US)",
volume = "112",
pages = "385--388",
journal = "Missouri Medicine",
issn = "0026-6620",
publisher = "Missouri State Medical Association",
number = "5",

}

TY - JOUR

T1 - The Evolution of Axillary Staging in Breast Cancer

AU - Rao, Roshni

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Breast cancer treatment has a long, fascinating history. Multimodality therapy utilizes surgery, systemic therapy and radiation. The role of surgical axillary staging in breast cancer continues to evolve. Secondary to randomized, controlled trials, sentinel lymph node biopsy is the standard for surgical staging in patients with a clinically negative axilla. Traditionally, when sentinel nodes revealed metastases, a complete axillary lymph node dissection was performed. Recently however, the value of complete axillary dissection is being challenged.

AB - Breast cancer treatment has a long, fascinating history. Multimodality therapy utilizes surgery, systemic therapy and radiation. The role of surgical axillary staging in breast cancer continues to evolve. Secondary to randomized, controlled trials, sentinel lymph node biopsy is the standard for surgical staging in patients with a clinically negative axilla. Traditionally, when sentinel nodes revealed metastases, a complete axillary lymph node dissection was performed. Recently however, the value of complete axillary dissection is being challenged.

UR - http://www.scopus.com/inward/record.url?scp=84956574718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956574718&partnerID=8YFLogxK

M3 - Article

C2 - 26606821

AN - SCOPUS:84956574718

VL - 112

SP - 385

EP - 388

JO - Missouri Medicine

JF - Missouri Medicine

SN - 0026-6620

IS - 5

ER -